nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.12	0.17	CbGbCtD
Ranolazine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.12	0.17	CbGbCtD
Ranolazine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.107	0.152	CbGbCtD
Ranolazine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.1	0.143	CbGbCtD
Ranolazine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0678	0.0966	CbGbCtD
Ranolazine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0647	0.0921	CbGbCtD
Ranolazine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0576	0.0821	CbGbCtD
Ranolazine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0338	0.0482	CbGbCtD
Ranolazine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0319	0.0455	CbGbCtD
Ranolazine—Bevantolol—ADRB2—chronic obstructive pulmonary disease	0.00175	0.16	CrCbGaD
Ranolazine—Levobupivacaine—CYP1A2—chronic obstructive pulmonary disease	0.00164	0.15	CrCbGaD
Ranolazine—Carvedilol—VEGFA—chronic obstructive pulmonary disease	0.00142	0.13	CrCbGaD
Ranolazine—Bupivacaine—CYP1A2—chronic obstructive pulmonary disease	0.00131	0.12	CrCbGaD
Ranolazine—Ropivacaine—CYP1A2—chronic obstructive pulmonary disease	0.00106	0.0966	CrCbGaD
Ranolazine—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000935	0.00333	CcSEcCtD
Ranolazine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000928	0.0033	CcSEcCtD
Ranolazine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000925	0.00329	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000922	0.00328	CcSEcCtD
Ranolazine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000919	0.00327	CcSEcCtD
Ranolazine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000911	0.00324	CcSEcCtD
Ranolazine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000911	0.00324	CcSEcCtD
Ranolazine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000908	0.00323	CcSEcCtD
Ranolazine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000903	0.00321	CcSEcCtD
Ranolazine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000903	0.00321	CcSEcCtD
Ranolazine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000899	0.0032	CcSEcCtD
Ranolazine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000899	0.0032	CcSEcCtD
Ranolazine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000892	0.00317	CcSEcCtD
Ranolazine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000892	0.00317	CcSEcCtD
Ranolazine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000891	0.00317	CcSEcCtD
Ranolazine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00089	0.00316	CcSEcCtD
Ranolazine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000886	0.00315	CcSEcCtD
Ranolazine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000886	0.00315	CcSEcCtD
Ranolazine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000885	0.00315	CcSEcCtD
Ranolazine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000885	0.00315	CcSEcCtD
Ranolazine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000882	0.00313	CcSEcCtD
Ranolazine—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00088	0.00313	CcSEcCtD
Ranolazine—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00088	0.00313	CcSEcCtD
Ranolazine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000875	0.00311	CcSEcCtD
Ranolazine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000873	0.0031	CcSEcCtD
Ranolazine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000867	0.00308	CcSEcCtD
Ranolazine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000866	0.00308	CcSEcCtD
Ranolazine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000864	0.00307	CcSEcCtD
Ranolazine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00086	0.00306	CcSEcCtD
Ranolazine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000853	0.00303	CcSEcCtD
Ranolazine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000852	0.00303	CcSEcCtD
Ranolazine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000846	0.00301	CcSEcCtD
Ranolazine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000846	0.00301	CcSEcCtD
Ranolazine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00084	0.00299	CcSEcCtD
Ranolazine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000836	0.00297	CcSEcCtD
Ranolazine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000835	0.00297	CcSEcCtD
Ranolazine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000831	0.00295	CcSEcCtD
Ranolazine—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00083	0.00295	CcSEcCtD
Ranolazine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000828	0.00295	CcSEcCtD
Ranolazine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000824	0.00293	CcSEcCtD
Ranolazine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000824	0.00293	CcSEcCtD
Ranolazine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00082	0.00292	CcSEcCtD
Ranolazine—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000819	0.00291	CcSEcCtD
Ranolazine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000807	0.00287	CcSEcCtD
Ranolazine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000805	0.00286	CcSEcCtD
Ranolazine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000804	0.00286	CcSEcCtD
Ranolazine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000804	0.00286	CcSEcCtD
Ranolazine—Carvedilol—ADRB2—chronic obstructive pulmonary disease	0.000799	0.0729	CrCbGaD
Ranolazine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000799	0.00284	CcSEcCtD
Ranolazine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000799	0.00284	CcSEcCtD
Ranolazine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000787	0.0028	CcSEcCtD
Ranolazine—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000783	0.00278	CcSEcCtD
Ranolazine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000778	0.00277	CcSEcCtD
Ranolazine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000777	0.00276	CcSEcCtD
Ranolazine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000777	0.00276	CcSEcCtD
Ranolazine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000771	0.00274	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000768	0.00273	CcSEcCtD
Ranolazine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000768	0.00273	CcSEcCtD
Ranolazine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000768	0.00273	CcSEcCtD
Ranolazine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000762	0.00271	CcSEcCtD
Ranolazine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000761	0.0027	CcSEcCtD
Ranolazine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000759	0.0027	CcSEcCtD
Ranolazine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000752	0.00267	CcSEcCtD
Ranolazine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000749	0.00266	CcSEcCtD
Ranolazine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000746	0.00265	CcSEcCtD
Ranolazine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000746	0.00265	CcSEcCtD
Ranolazine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000746	0.00265	CcSEcCtD
Ranolazine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000746	0.00265	CcSEcCtD
Ranolazine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000745	0.00265	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000744	0.00264	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000744	0.00264	CcSEcCtD
Ranolazine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000734	0.00261	CcSEcCtD
Ranolazine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000733	0.0026	CcSEcCtD
Ranolazine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000733	0.0026	CcSEcCtD
Ranolazine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000731	0.0026	CcSEcCtD
Ranolazine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00073	0.0026	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000729	0.00259	CcSEcCtD
Ranolazine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000728	0.00259	CcSEcCtD
Ranolazine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000725	0.00258	CcSEcCtD
Ranolazine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000707	0.00251	CcSEcCtD
Ranolazine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000705	0.00251	CcSEcCtD
Ranolazine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000704	0.0025	CcSEcCtD
Ranolazine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000704	0.0025	CcSEcCtD
Ranolazine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000703	0.0025	CcSEcCtD
Ranolazine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000697	0.00248	CcSEcCtD
Ranolazine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000697	0.00248	CcSEcCtD
Ranolazine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000692	0.00246	CcSEcCtD
Ranolazine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00069	0.00245	CcSEcCtD
Ranolazine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000689	0.00245	CcSEcCtD
Ranolazine—Carvedilol—CYP1A1—chronic obstructive pulmonary disease	0.000685	0.0625	CrCbGaD
Ranolazine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000683	0.00243	CcSEcCtD
Ranolazine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000671	0.00239	CcSEcCtD
Ranolazine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000671	0.00239	CcSEcCtD
Ranolazine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00067	0.00238	CcSEcCtD
Ranolazine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000667	0.00237	CcSEcCtD
Ranolazine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000667	0.00237	CcSEcCtD
Ranolazine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000665	0.00236	CcSEcCtD
Ranolazine—Carvedilol—CYP1A2—chronic obstructive pulmonary disease	0.000661	0.0603	CrCbGaD
Ranolazine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000659	0.00234	CcSEcCtD
Ranolazine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000655	0.00233	CcSEcCtD
Ranolazine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000649	0.00231	CcSEcCtD
Ranolazine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000649	0.00231	CcSEcCtD
Ranolazine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000646	0.0023	CcSEcCtD
Ranolazine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00064	0.00228	CcSEcCtD
Ranolazine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00064	0.00228	CcSEcCtD
Ranolazine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000638	0.00227	CcSEcCtD
Ranolazine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000638	0.00227	CcSEcCtD
Ranolazine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000636	0.00226	CcSEcCtD
Ranolazine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000634	0.00225	CcSEcCtD
Ranolazine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000632	0.00225	CcSEcCtD
Ranolazine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000632	0.00225	CcSEcCtD
Ranolazine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000632	0.00225	CcSEcCtD
Ranolazine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000629	0.00224	CcSEcCtD
Ranolazine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000625	0.00222	CcSEcCtD
Ranolazine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000624	0.00222	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00062	0.0022	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00062	0.0022	CcSEcCtD
Ranolazine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000619	0.0022	CcSEcCtD
Ranolazine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000619	0.0022	CcSEcCtD
Ranolazine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000619	0.0022	CcSEcCtD
Ranolazine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000614	0.00218	CcSEcCtD
Ranolazine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000614	0.00218	CcSEcCtD
Ranolazine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000613	0.00218	CcSEcCtD
Ranolazine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000612	0.00218	CcSEcCtD
Ranolazine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000609	0.00216	CcSEcCtD
Ranolazine—Propranolol—ADRB2—chronic obstructive pulmonary disease	0.000608	0.0554	CrCbGaD
Ranolazine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000607	0.00216	CcSEcCtD
Ranolazine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000606	0.00216	CcSEcCtD
Ranolazine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000604	0.00215	CcSEcCtD
Ranolazine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000603	0.00214	CcSEcCtD
Ranolazine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.0006	0.00213	CcSEcCtD
Ranolazine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000597	0.00212	CcSEcCtD
Ranolazine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000595	0.00211	CcSEcCtD
Ranolazine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000594	0.00211	CcSEcCtD
Ranolazine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000592	0.0021	CcSEcCtD
Ranolazine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000592	0.0021	CcSEcCtD
Ranolazine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000591	0.0021	CcSEcCtD
Ranolazine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000589	0.0021	CcSEcCtD
Ranolazine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000588	0.00209	CcSEcCtD
Ranolazine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000587	0.00209	CcSEcCtD
Ranolazine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000587	0.00209	CcSEcCtD
Ranolazine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000587	0.00209	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000585	0.00208	CcSEcCtD
Ranolazine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000585	0.00208	CcSEcCtD
Ranolazine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00058	0.00206	CcSEcCtD
Ranolazine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000575	0.00204	CcSEcCtD
Ranolazine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00057	0.00203	CcSEcCtD
Ranolazine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00057	0.00203	CcSEcCtD
Ranolazine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000568	0.00202	CcSEcCtD
Ranolazine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000568	0.00202	CcSEcCtD
Ranolazine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000566	0.00201	CcSEcCtD
Ranolazine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000561	0.00199	CcSEcCtD
Ranolazine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00056	0.00199	CcSEcCtD
Ranolazine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00056	0.00199	CcSEcCtD
Ranolazine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000559	0.00199	CcSEcCtD
Ranolazine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000559	0.00199	CcSEcCtD
Ranolazine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000557	0.00198	CcSEcCtD
Ranolazine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000557	0.00198	CcSEcCtD
Ranolazine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000556	0.00198	CcSEcCtD
Ranolazine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000554	0.00197	CcSEcCtD
Ranolazine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000539	0.00191	CcSEcCtD
Ranolazine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000536	0.00191	CcSEcCtD
Ranolazine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000528	0.00188	CcSEcCtD
Ranolazine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000527	0.00188	CcSEcCtD
Ranolazine—Propranolol—CYP1A1—chronic obstructive pulmonary disease	0.000521	0.0475	CrCbGaD
Ranolazine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000515	0.00183	CcSEcCtD
Ranolazine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000515	0.00183	CcSEcCtD
Ranolazine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000508	0.00181	CcSEcCtD
Ranolazine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000508	0.00181	CcSEcCtD
Ranolazine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000505	0.00179	CcSEcCtD
Ranolazine—Propranolol—CYP1A2—chronic obstructive pulmonary disease	0.000503	0.0458	CrCbGaD
Ranolazine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000498	0.00177	CcSEcCtD
Ranolazine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000489	0.0863	CbGpPWpGaD
Ranolazine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000489	0.00174	CcSEcCtD
Ranolazine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000487	0.00173	CcSEcCtD
Ranolazine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000486	0.00173	CcSEcCtD
Ranolazine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00048	0.00171	CcSEcCtD
Ranolazine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000475	0.00169	CcSEcCtD
Ranolazine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000475	0.00169	CcSEcCtD
Ranolazine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000465	0.00165	CcSEcCtD
Ranolazine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000458	0.00163	CcSEcCtD
Ranolazine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000457	0.00162	CcSEcCtD
Ranolazine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000457	0.00162	CcSEcCtD
Ranolazine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000453	0.00161	CcSEcCtD
Ranolazine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000453	0.00161	CcSEcCtD
Ranolazine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000452	0.00161	CcSEcCtD
Ranolazine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000452	0.00161	CcSEcCtD
Ranolazine—Headache—Formoterol—chronic obstructive pulmonary disease	0.00045	0.0016	CcSEcCtD
Ranolazine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00045	0.0016	CcSEcCtD
Ranolazine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.00045	0.0016	CcSEcCtD
Ranolazine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000449	0.0016	CcSEcCtD
Ranolazine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00159	CcSEcCtD
Ranolazine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000447	0.00159	CcSEcCtD
Ranolazine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000443	0.00158	CcSEcCtD
Ranolazine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000443	0.00157	CcSEcCtD
Ranolazine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000441	0.00157	CcSEcCtD
Ranolazine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000435	0.00155	CcSEcCtD
Ranolazine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000432	0.0763	CbGpPWpGaD
Ranolazine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.00153	CcSEcCtD
Ranolazine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000428	0.00152	CcSEcCtD
Ranolazine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00152	CcSEcCtD
Ranolazine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000427	0.00152	CcSEcCtD
Ranolazine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00152	CcSEcCtD
Ranolazine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000426	0.00152	CcSEcCtD
Ranolazine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000426	0.00152	CcSEcCtD
Ranolazine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000425	0.00151	CcSEcCtD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—TNNT2—chronic obstructive pulmonary disease	0.000421	0.0742	CbGpPWpGaD
Ranolazine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000419	0.00149	CcSEcCtD
Ranolazine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000418	0.00149	CcSEcCtD
Ranolazine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000405	0.00144	CcSEcCtD
Ranolazine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000403	0.00143	CcSEcCtD
Ranolazine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000396	0.00141	CcSEcCtD
Ranolazine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000391	0.00139	CcSEcCtD
Ranolazine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000383	0.00136	CcSEcCtD
Ranolazine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000376	0.00134	CcSEcCtD
Ranolazine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000372	0.00132	CcSEcCtD
Ranolazine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000361	0.00128	CcSEcCtD
Ranolazine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000355	0.00126	CcSEcCtD
Ranolazine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000354	0.0624	CbGpPWpGaD
Ranolazine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000352	0.00125	CcSEcCtD
Ranolazine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000349	0.00124	CcSEcCtD
Ranolazine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000348	0.00124	CcSEcCtD
Ranolazine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000346	0.00123	CcSEcCtD
Ranolazine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000326	0.00116	CcSEcCtD
Ranolazine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00032	0.00114	CcSEcCtD
Ranolazine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000316	0.00112	CcSEcCtD
Ranolazine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000311	0.00111	CcSEcCtD
Ranolazine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00031	0.0011	CcSEcCtD
Ranolazine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000309	0.0011	CcSEcCtD
Ranolazine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000304	0.00108	CcSEcCtD
Ranolazine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000294	0.00104	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000293	0.00104	CcSEcCtD
Ranolazine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000278	0.000988	CcSEcCtD
Ranolazine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000277	0.000985	CcSEcCtD
Ranolazine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000976	CcSEcCtD
Ranolazine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000273	0.000971	CcSEcCtD
Ranolazine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000958	CcSEcCtD
Ranolazine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.000914	CcSEcCtD
Ranolazine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000909	CcSEcCtD
Ranolazine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000254	0.000902	CcSEcCtD
Ranolazine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000249	0.000884	CcSEcCtD
Ranolazine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000246	0.000873	CcSEcCtD
Ranolazine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000245	0.000872	CcSEcCtD
Ranolazine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000245	0.000871	CcSEcCtD
Ranolazine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000244	0.000866	CcSEcCtD
Ranolazine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000244	0.000866	CcSEcCtD
Ranolazine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000242	0.000859	CcSEcCtD
Ranolazine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000828	CcSEcCtD
Ranolazine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000821	CcSEcCtD
Ranolazine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.000821	CcSEcCtD
Ranolazine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000798	CcSEcCtD
Ranolazine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000794	CcSEcCtD
Ranolazine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000721	CcSEcCtD
Ranolazine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000711	CcSEcCtD
Ranolazine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000664	CcSEcCtD
Ranolazine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000639	CcSEcCtD
Ranolazine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00018	0.0317	CbGpPWpGaD
Ranolazine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000633	CcSEcCtD
Ranolazine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000633	CcSEcCtD
Ranolazine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000629	CcSEcCtD
Ranolazine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000597	CcSEcCtD
Ranolazine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000142	0.025	CbGpPWpGaD
Ranolazine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000138	0.0243	CbGpPWpGaD
Ranolazine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000119	0.0209	CbGpPWpGaD
Ranolazine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.0201	CbGpPWpGaD
Ranolazine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000107	0.0188	CbGpPWpGaD
Ranolazine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.0182	CbGpPWpGaD
Ranolazine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	9.27e-05	0.0163	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	9.02e-05	0.0159	CbGpPWpGaD
Ranolazine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	8.81e-05	0.0155	CbGpPWpGaD
Ranolazine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	8.62e-05	0.0152	CbGpPWpGaD
Ranolazine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	8.43e-05	0.0149	CbGpPWpGaD
Ranolazine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	8.29e-05	0.0146	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	8.14e-05	0.0144	CbGpPWpGaD
Ranolazine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	8.08e-05	0.0142	CbGpPWpGaD
Ranolazine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	7.75e-05	0.0137	CbGpPWpGaD
Ranolazine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	7.46e-05	0.0132	CbGpPWpGaD
Ranolazine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	6.83e-05	0.012	CbGpPWpGaD
Ranolazine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	6.73e-05	0.0119	CbGpPWpGaD
Ranolazine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	6.46e-05	0.0114	CbGpPWpGaD
Ranolazine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	6.4e-05	0.0113	CbGpPWpGaD
Ranolazine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	6.13e-05	0.0108	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	5.64e-05	0.00995	CbGpPWpGaD
Ranolazine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	5.63e-05	0.00994	CbGpPWpGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—chronic obstructive pulmonary disease	5.45e-05	0.00962	CbGpPWpGaD
Ranolazine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	5.42e-05	0.00956	CbGpPWpGaD
Ranolazine—SCN9A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	5.34e-05	0.00942	CbGpPWpGaD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	5.07e-05	0.00894	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	5.04e-05	0.00888	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	4.99e-05	0.00881	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	4.92e-05	0.00869	CbGpPWpGaD
Ranolazine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	4.86e-05	0.00857	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	4.77e-05	0.00842	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	3.99e-05	0.00704	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	3.98e-05	0.00702	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.58e-05	0.00631	CbGpPWpGaD
Ranolazine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.53e-05	0.00623	CbGpPWpGaD
Ranolazine—SCN5A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	3.33e-05	0.00587	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	3.29e-05	0.00581	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	3.22e-05	0.00568	CbGpPWpGaD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	3.18e-05	0.0056	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	3.09e-05	0.00544	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	2.97e-05	0.00524	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—LEP—chronic obstructive pulmonary disease	2.96e-05	0.00523	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	2.96e-05	0.00522	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.9e-05	0.00512	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	2.89e-05	0.0051	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	2.61e-05	0.0046	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.55e-05	0.0045	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.52e-05	0.00445	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	2.51e-05	0.00442	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MMP9—chronic obstructive pulmonary disease	2.5e-05	0.0044	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	2.34e-05	0.00413	CbGpPWpGaD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	2.31e-05	0.00407	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	2.24e-05	0.00395	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	2.15e-05	0.00379	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.12e-05	0.00374	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.09e-05	0.00369	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—EGFR—chronic obstructive pulmonary disease	2.02e-05	0.00356	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1.9e-05	0.00334	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—LEP—chronic obstructive pulmonary disease	1.85e-05	0.00326	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.78e-05	0.00314	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.77e-05	0.00312	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.74e-05	0.00308	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.73e-05	0.00306	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.67e-05	0.00294	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.65e-05	0.00291	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.63e-05	0.00287	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.6e-05	0.00283	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.6e-05	0.00282	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MMP9—chronic obstructive pulmonary disease	1.56e-05	0.00274	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—IL6—chronic obstructive pulmonary disease	1.55e-05	0.00273	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.54e-05	0.00272	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.52e-05	0.00268	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.47e-05	0.00259	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.44e-05	0.00254	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	1.4e-05	0.00246	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.39e-05	0.00245	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.37e-05	0.00242	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.37e-05	0.00241	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—EGFR—chronic obstructive pulmonary disease	1.26e-05	0.00222	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.24e-05	0.00219	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.16e-05	0.00204	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.14e-05	0.00201	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.11e-05	0.00196	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.11e-05	0.00195	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.06e-05	0.00187	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.05e-05	0.00185	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.01e-05	0.00178	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	9.96e-06	0.00176	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.93e-06	0.00175	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	9.66e-06	0.0017	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	9.15e-06	0.00161	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	8.97e-06	0.00158	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	8.54e-06	0.00151	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.21e-06	0.00145	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	8.1e-06	0.00143	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	7.99e-06	0.00141	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.43e-06	0.00131	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	6.89e-06	0.00122	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.37e-06	0.000947	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	5.22e-06	0.000921	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.85e-06	0.000856	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.36e-06	0.00077	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	4.31e-06	0.000761	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	3.94e-06	0.000694	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.63e-06	0.00064	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.02e-06	0.000533	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.98e-06	0.000526	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.85e-06	0.000503	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.82e-06	0.000497	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.78e-06	0.00049	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.63e-06	0.000465	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.57e-06	0.000454	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.37e-06	0.000418	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.98e-06	0.000349	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.95e-06	0.000344	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.82e-06	0.000321	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.79e-06	0.000316	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.72e-06	0.000304	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.71e-06	0.000302	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.17e-06	0.000207	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.12e-06	0.000198	CbGpPWpGaD
